#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic hepatitis B T-cell type acute leukaemia Rett syndrome Amyotrophic lateral sclerosis gene carrier Myelin oligodendrocyte glycoprotein antibody-associated disease Thrombocytosis Head and neck cancer Medulloblastoma recurrent Vulval cancer recurrent Oesophageal adenocarcinoma stage II Acute respiratory distress syndrome Acute lymphocytic leukaemia Ductal adenocarcinoma of pancreas Arteriovenous malformation Mucopolysaccharidosis III More trials…

    Learn about Rare Diseases

    Leiomyosarcoma metastatic – Treatment Propionic acidaemia – Life with Disease Bronchiolitis obliterans syndrome – Basic Information Aicardi-Goutieres syndrome – Diagnostics Turner’s syndrome Small intestine leiomyosarcoma – Diagnostics Mastocytosis Factor VIII deficiency – Basic Information Inclusion body myositis – Life with Disease Haemophilia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Meropenem Trihydrate Gefitinib Lovastatin Fezolinetant Taminadenant Phenol, Liquefied GSKVX000000048110 Cariprazine Cenobamate Mk-1167 Elenestinib Phosphate Ralinepag RNMB2 Imifoplatin Protrans Doconexent Taxanes Donidalorsen Psma-11 Blomia Tropicalis More therapies…

    Learn about Your Condition

    Laryngeal leukoplakia Cachexia Myelodysplastic syndrome Drug dependence Periarthritis Liposarcoma recurrent Thyroid mass Normal pressure hydrocephalus Ectopic pregnancy Actinic keratosis Primary myelofibrosis Alport's syndrome Myeloproliferative neoplasm Astrocytoma malignant Pyelonephritis acute More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study to evaluate the effects of CSX-1004 on breathing difficulties caused by fentanyl in healthy adults and people with opioid use disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Drug use disorder
    Investigated Drugs:
    • Sodium Chloride
    The Netherlands

  • Safety of injecting bupivacaine and dexamethasone into the parotid gland for patients undergoing surgery for a benign parotid tumor

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Salivary gland cancer
    Investigated Drugs:
    • Bupivacaine Hydrochloride
    • Epinephrine
    • Dexamethasone Acetate
    France

  • A study of ABBV-706 and atezolizumab for patients with previously untreated extensive stage small cell lung cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST SEZ6, CONJUGATED TO (2S)-2-(2-BROMOACETAMIDO)-N-[(2S)-1-({3-[(7S)-7-ETHYL-7-HYDROXY-8,11-DIOXO-7,8,11,13-TETRAHYDRO-2H,10H-[1,3]DIOXOLO[4,5-G]PYRANO[3′,4′:6,7]INDOLIZINO[1,2-B]QUINOLIN-14-YL]BICYCLO[1.1.1]PENTAN-1-YL}AMINO)-1-OXOPROPAN-2-YL]-3-METHYLBUTANAMIDE
    • Atezolizumab
    • Carboplatin
    Belgium Germany Italy Poland Spain

  • A study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis

    Recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Morf-057
    • Mirikizumab
    Austria Denmark Germany Hungary Italy The Netherlands +3

  • A study to evaluate the safety and effectiveness of AZD0292 in people aged 12 years and older with bronchiectasis and chronic Pseudomonas aeruginosa infection

    Recruiting

    2 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • AZD0292
    Belgium Denmark France Germany Greece Italy +2

  • Study of guselkumab and dietary changes for patients with recurring or difficult-to-treat pouchitis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pouchitis
    Investigated Drugs:
    • Guselkumab
    Belgium
Previous Page
1 … 41 42 43 44 45 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!